IBM Shares Retreat as Quantum Race Intensifies and Higher Yields Eclipse Analyst Enthusiasm

IBM shares fell up to 3.2% despite analyst upgrades, pressured by rising bond yields, strong ADP jobs data, and Microsoft's new Majorana-2 quantum chip unveiling.

IBM stock gave back some of its recent stellar gains on Thursday, slipping between 2.7% and 3.2% depending on the data source, with one exchange closing at 255.35 euros and another at 256.80 euros. The pullback came despite a fresh wave of analyst upgrades—including a lofty new price target from Citi—and followed a rally that had lifted the shares more than 30% in the past month.

Three interrelated factors converged to pressure the stock. Rising US bond yields, a stronger-than-expected ADP employment report showing 122,000 new jobs in May against forecasts of 110,000, and a direct competitive threat from Microsoft’s new Majorana-2 quantum chip all weighed on sentiment. The robust labor data pushed expectations for interest rate cuts further into the future, a headwind for capital?intensive companies like IBM that depend on corporate investment. Meanwhile, Microsoft’s chip unveiling at its Build conference on June 2 set the same 2029 target for commercially viable quantum computing that IBM has staked its own roadmap on, sharpening the competitive picture significantly.

The rally that preceded this retreat was ignited by IBM’s promise to plow more than $10 billion into quantum computing over five years, aiming to build the first large?scale, fault?tolerant quantum computer by 2029. Citi responded by lifting its price target to $375 from $285 on June 2, maintaining a buy rating and arguing that the market has “underestimated” and “misunderstood” IBM’s quantum push. The timing of the investment—following the award of US Chips Act funding—underscores the company’s confidence, Citi added. Barclays also joined the bullish chorus, initiating coverage with an Overweight rating and a $350 target, drawing parallels to Nvidia’s success story and pointing to IBM’s defensive software portfolio as a stable earnings base.

Beyond the quantum narrative, IBM’s structural position has strengthened. The company is a key partner for Nvidia’s Vera?Rubin platform, supplying cloud capacity for agent?based AI workloads with confidential computing. IBM currently operates the world’s largest fleet of quantum computers—over 90 systems used by more than 340 organizations—giving it a tangible lead even as Microsoft enters the race.

Fundamentals remain solid. In the first quarter of 2026, software revenue reached $7.05 billion, up 11.3%, while infrastructure revenue grew 15.3% on a strong IBM Z mainframe cycle. Free cash flow for the full year is targeted at roughly $14.7 billion plus an additional $1 billion year?on?year. However, the acquisition of Confluent—a data?streaming platform used by more than 6,500 companies—has added significant debt. Should IBM’s leverage ratio exceed 2.5x, S&P Global could cut its credit rating, limiting future financial flexibility.

Technically, the stock is not yet overbought, with the RSI at 64.5, but the annualized 30?day volatility of nearly 65% leaves it vulnerable to further swings. The 52?week high of 292.85 euros is roughly 13% above current levels, and the 50?day and 200?day moving averages sit at 209.85 and 234.36 euros respectively, underscoring how far the shares have climbed. All eyes now turn to IBM’s second?quarter earnings on July 22, when management will need to back up the quantum timeline with concrete progress—and prove the rally can sustain itself beyond the upgrade?driven frenzy.